thrive glp 1 reviews consumer reports A new systematic review and meta-regression of GLP-1 drug cessation and % of weight regained >1 year later is looking more positive than a lot of online clips, Full paper is open access, find it by Consumers Taking GLP-1s for Weight

Looking for a simpler fix

Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, et al

Unleash the ultra Beast

The reduction of N-terminal pro-B-type natriuretic peptide (NT-proBNP) was 15% more than placebo, this being an important change in a surrogate marker for improving heart function

Some GLP-1 medications have demonstrated cardiovascular protective effects in specific populationsliraglutide, semaglutide injection, and dulaglutide have shown cardiovascular outcome benefits, with Wegovy (semaglutide) recently receiving an FDA indication for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity

I have never once had any concerns or issues about rules and regulations like many of the others